✦ LIBER ✦

59 Adjuvant therapy for stage II or III breast cancer based on the hormone receptor status — a pilot study comparing antiestrogen and chemotherapy

✍ Scribed by W. Jonat; H. Maass; M. Braun

Book ID: 116003512
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 90 KB
Volume: 19
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(83)91559-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interpreting breast international group

Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

✍ Meredith M Regan; Karen N Price; Anita Giobbie-Hurder; Beat Thürlimann; Richard 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 368 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views